Innovation Pharmaceuticals Inc (IPIX): Quote “The Company intends to provide...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Friday, 05/28/2021 4:21:39 PM

Friday, May 28, 2021 4:21:39 PM

Quote

“The Company intends to provide an update to shareholders upon the final patients entering the trial.”

http://www.ipharminc.com/press-release/2021/5/27/patient-enrollment-reaches-90-percent-in-innovation-pharmas-phase-2-clinical-trial-of-brilacidin-for-covid-19

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

Only $200 per official company press release!